company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 17:18:11+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6017581.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 17:18:11+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6017581.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 17:18:11+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,9359.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 17:18:11+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,0.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 17:18:11+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1745760.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 17:18:11+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,121728.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 17:18:11+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4140734.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 17:18:11+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4140734.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 17:18:11+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-26395.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 17:18:11+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,0.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 17:18:11+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,0.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 17:18:11+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-26395.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 17:18:11+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-26395.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 17:18:11+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,80435430.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 17:18:11+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,400000.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 17:18:11+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,80835430.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 17:18:11+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,80835430.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 17:18:11+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,76668301.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7078398.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7078398.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,11355.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1640559.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,961870.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4464614.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4464614.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-49167.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-49167.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-49167.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2999.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2999.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2999.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4510782.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8152844.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8152844.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,16084.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1192.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1506679.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-74572.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-6703461.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-6703461.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-147703.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-21002641.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,10998295.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-10152049.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-10152049.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,3373.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3373.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3373.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-16852137.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7892807.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7892807.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,13083.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,8331.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1708484.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,725600.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5437309.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5437309.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-42352.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-18395128.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1400000.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-17037480.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-17037480.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1949.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1949.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1949.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-22472840.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:48:40+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9592461.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:48:40+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9592461.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:48:40+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,30813.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:48:40+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,46129.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:48:40+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1518161.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:48:40+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1176266.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:48:40+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9173624.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:48:40+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9173624.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:48:40+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-107286.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:48:40+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-12013945.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:48:40+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,0.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:48:40+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,8600195.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:48:40+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3521036.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:48:40+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3521036.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:48:40+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,7594.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:48:40+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,7594.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:48:40+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,7594.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:48:40+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-12687066.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11363133.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11363133.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,59145.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,32622.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1988321.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-44538.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9327583.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9327583.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-182916.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-10060905.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,4512565.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-5731256.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-5731256.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,449.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,449.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,449.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-15058390.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q3,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10637494.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10637494.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,75415.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,38485.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1860588.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1410876.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7252130.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7252130.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-218785.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-6011836.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2357050.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q3,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3873571.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3873571.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,14053.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,14053.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,14053.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q3,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-11111648.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7900035.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7900035.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,111858.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-101075.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1209327.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,381149.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-6298776.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-6298776.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-50391.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-10595395.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,5255.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,11525514.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q4,2016-10-01,2016-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,884983.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,884983.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q4,2016-10-01,2016-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5413791.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 16:48:40+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8268395.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 16:48:40+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8268395.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 16:48:40+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,91367.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 16:48:40+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2454.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 16:48:40+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1188752.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 16:48:40+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1239770.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 16:48:40+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8225592.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 16:48:40+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8225592.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 16:48:40+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-22150.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 16:48:40+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-9607422.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 16:48:40+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,732.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 16:48:40+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,16510076.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 16:48:40+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,6881236.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 16:48:40+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,6881236.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 16:48:40+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 16:48:40+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,0.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 16:48:40+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1344356.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8804623.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8804623.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,79742.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-18349.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1073346.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1979929.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5689955.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5689955.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-31591.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,32.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,2643.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,23771941.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,23743025.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,23743025.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2047.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2047.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2047.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,18055117.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9332113.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9332113.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,79454.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-22656.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1004781.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,219188.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8051346.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8051346.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-44359.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-13757331.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,858.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,3004101.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-10796731.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-10796731.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-18848077.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8028531.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8028531.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,73985.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-29588.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,954067.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1274762.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5755305.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5755305.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-15398.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-9622976.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,1111.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,14299295.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,4662032.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,4662032.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,585.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,585.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,585.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q4,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1092688.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:11:19+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8223227.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:11:19+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8223227.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:11:19+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,64066.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:11:19+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,12231.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:11:19+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,905460.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:11:19+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2171017.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:11:19+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9412487.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:11:19+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9412487.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:11:19+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1997751.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:11:19+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,500.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:11:19+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,14117184.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:11:19+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,12119933.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:11:19+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,12119933.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:11:19+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,54913.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:11:19+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,54913.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:11:19+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,54913.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:11:19+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,2762359.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q2,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9051872.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9051872.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,59934.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-694.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,536747.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,200449.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8255436.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8255436.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,915.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2000000.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,2000915.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,2000915.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,63097.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,63097.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,63097.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q2,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-6191424.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q3,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,16697333.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,16697333.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,-111287.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-11537.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-77600.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4960665.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,21457574.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,21457574.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,1997751.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,-1415.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,-16117184.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q3,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-14120848.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-14120848.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-250000.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-58959.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2050269.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-118010.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1623300.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1623300.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q3,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,8960026.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1091871.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1091871.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,4237.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-1333646.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2808818.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,387538.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,387538.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-365014.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,58959.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-25000.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,25000.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-306055.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-306055.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q4,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,81483.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q1,2019-01-01,2019-03-31,2019-05-01 16:11:19+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2230430.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q1,2019-01-01,2019-03-31,2019-05-01 16:11:19+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2230430.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q1,2019-01-01,2019-03-31,2019-05-01 16:11:19+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,36452.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q1,2019-01-01,2019-03-31,2019-05-01 16:11:19+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,0.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q1,2019-01-01,2019-03-31,2019-05-01 16:11:19+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,220975.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q1,2019-01-01,2019-03-31,2019-05-01 16:11:19+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-685748.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q1,2019-01-01,2019-03-31,2019-05-01 16:11:19+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-2658751.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q1,2019-01-01,2019-03-31,2019-05-01 16:11:19+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-2658751.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q1,2019-01-01,2019-03-31,2019-05-01 16:11:19+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,0.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q1,2019-01-01,2019-03-31,2019-05-01 16:11:19+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,0.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q1,2019-01-01,2019-03-31,2019-05-01 16:11:19+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,0.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q1,2019-01-01,2019-03-31,2019-05-01 16:11:19+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,0.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q1,2019-01-01,2019-03-31,2019-05-01 16:11:19+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q1,2019-01-01,2019-03-31,2019-05-01 16:11:19+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,0.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q1,2019-01-01,2019-03-31,2019-05-01 16:11:19+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2658751.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q2,2019-04-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1384777.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1384777.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,10054.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,212547.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,378923.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-783253.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-783253.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q2,2019-04-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-783253.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q3,2019-07-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1438235.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1438235.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,76668.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-984649.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3153801.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5500017.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5501534.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,5607908.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q3,2019-07-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,5607908.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,5607908.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-171060.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-133594.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1508179.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1203525.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1203525.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q3,2019-07-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1309899.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1882821.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1882821.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,4234.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-8588.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-750900.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-2638075.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-2636558.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-246825.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2622607.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2375782.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2375782.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q4,2019-10-01,2019-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-260776.0
